| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CMIG4
|
10.70 | 30.6B | 6.29 | 1.07 | 5.51 | 20,964.5% | 14.8% | 69 | 54 | 18.09 | +51.8% | 64 | 0.70 |
|
CPFE3
|
44.54 | 51.3B | 8.90 | 2.11 | 6.39 | 14.5% | 12.5% | 67 | 49 | 64.26 | +33.2% | 61 | 1.48 |
|
SBSP3
|
25.28 | 88.7B | 10.16 | 2.03 | 7.44 | 10.4% | 12.4% | 55 | 33 | 27.64 | +6.7% | 63 | 1.18 |
|
EGIE3
|
29.38 | 41.6B | 16.22 | 3.06 | 8.79 | 11.2% | 12.1% | 47 | 37 | 23.68 | -13.0% | 56 | 2.33 |
|
CPLE6
|
14.95 | 44.4B | 16.35 | 1.86 | 10.66 | 7.7% | 14.1% | 46 | 27 | 12.70 | -10.1% | 57 | 0.99 |
|
AURE3
|
11.19 | 11.7B | — | 0.98 | 9.75 | 3.1% | 12.0% | 44 | 41 | 15.96 | +21.7% | 30 | 2.00 |
|
TAEE11
|
39.10 | 40.4B | 25.77 | 5.08 | 18.86 | 10.7% | 15.3% | 37 | 26 | 17.30 | -41.8% | 62 | 1.47 |
|
EQTL3
|
36.67 | 46.0B | 29.76 | 1.79 | 9.28 | 9.9% | 11.9% | 34 | 36 | 24.62 | -22.0% | 46 | 2.22 |
|
ENGI11
|
48.00 | 120.7B | 73.68 | 6.14 | 18.03 | 7.8% | 15.1% | 27 | 27 | 16.45 | -42.1% | 48 | 2.33 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.